Oncology Vol 33 No 4

An oncology pharmacist discusses how to prevent and treat the toxicities from regorafenib for the treatment of colorectal cancer.

A 39-year-old woman with no significant medical history presented to the emergency department with progressive diffuse abdominal pain, involuntary weight loss, anemic syndrome, and limitation of mobility. What is the best treatment course to follow?

In this article, important concepts in the molecular testing of non–small-cell lung cancer are highlighted.

Dr. Balar highlights promising evidence on the potential benefits of the use of immunotherapy in the advanced bladder cancer setting.

Dr. McArthur discusses the latest results of immunotherapy trials in the treatment of triple-negative breast cancer.

This article reviews patient requests and how they may be in contrast with guidelines, and provides recommendations from a community oncology practice perspective.

This review summarizes the current available treatment strategies for patients with advanced melanoma when PD-1–directed therapy is not enough.

In this article, we review the current use of and future direction for genetic testing and tumor profiling in patients with metastatic castration-resistant prostate cancer.